Patient-reported adverse drug reactions and their influence on adherence and quality of life of chronic myeloid leukemia patients on per oral tyrosine kinase inhibitor treatment

PURPOSE: To evaluate adverse drug reactions (ADRs) experienced by chronic myeloid leukemia (CML) patients during per oral tyrosine kinase inhibitor (TKI) treatment and correlation of ADR symptoms with medication adherence and perceived quality of life (QoL). PATIENTS AND METHODS: Eighty-six adult, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kekäle, Meri, Peltoniemi, Marikki, Airaksinen, Marja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677761/
https://www.ncbi.nlm.nih.gov/pubmed/26677317
http://dx.doi.org/10.2147/PPA.S92125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677761/
https://www.ncbi.nlm.nih.gov/pubmed/26677317
http://dx.doi.org/10.2147/PPA.S92125

Ejemplares similares